SMART, SZBL and Sanofi form alliance

Shenzhen Medical Academy of Research and Translation (SMART), Shenzhen Bay Laboratory (SZBL), and Sanofi signed a strategic cooperation agreement on July 28 to establish the SMART-SZBL-Sanofi Strategic Science and Innovation Alliance (SSSIA). The tripartite partnership aims to accelerate the translation of innovative therapies from bench to bedside.

The alliance will focus on developing novel treatments for inflammatory and autoimmune diseases, with particular emphasis on rare diseases, neurology, oncology, transplantation, Type 1 diabetes, and other autoimmune conditions.

Collaboration will be organized around six key pillars: translational research, clinical studies, shared technology platforms, commercialization and industrialization of technology achievements, talent development, and incubator support.